Horace Mann Educators (HMN)
(Delayed Data from NYSE)
$33.76 USD
+0.11 (0.33%)
Updated May 24, 2024 04:00 PM ET
After-Market: $33.73 -0.03 (-0.09%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth D Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$33.76 USD
+0.11 (0.33%)
Updated May 24, 2024 04:00 PM ET
After-Market: $33.73 -0.03 (-0.09%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth D Momentum A VGM
Zacks News
MetLife (MET) Q4 Earnings and Revenues Lag Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of -10.92% and 6.58%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Horace Mann (HMN) Q4 Earnings Expected to Decline
by Zacks Equity Research
Horace Mann (HMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why One Should Retain Radian Group (RDN) Stock Now
by Zacks Equity Research
Radian Group (RDN) is well-poised to grow driven by higher persistency, strong-performing real estate services and sufficient liquidity.
Is It Time to Add Horace Mann (HMN) Stock to Your Kitty Now?
by Zacks Equity Research
A focus on improving product offerings, strengthening distribution and modernizing infrastructure bodes well for Horace Mann (HMN).
Horace Mann (HMN) Q3 Earnings Beat Estimates
by Zacks Equity Research
Horace Mann (HMN) delivered earnings and revenue surprises of 17.86% and 2.52%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
MetLife (MET) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 2.54% and 19.12%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Lemonade (LMND) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Lemonade (LMND) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Horace Mann (HMN) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Horace Mann (HMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for Everest Re (RE) in Q3 Earnings?
by Zacks Equity Research
Everest Re's (RE) Q3 results are likely to benefit from increases across all lines of business, strong renewal retention and growth in international operations, offset by higher cat loss.
Marsh & McLennan (MMC) Q3 Earnings Beat, Revenues Rise Y/Y
by Zacks Equity Research
Marsh & McLennan's (MMC) third-quarter results reflect solid segmental contributions. Though robust international operations aid the Risk and Insurance Services segment, high costs dampen earnings.
Chubb's (CB) Q3 Earnings Coming Up: What's in the Cards?
by Zacks Equity Research
Chubb's (CB) Q3 earnings are likely to reflect higher premiums and improved net investment income, offset by higher expenses.
W.R. Berkley (WRB) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Higher premium growth, increased net investment income and an improved expense ratio are likely to have aided W.R. Berkley's (WRB) third-quarter performance. The results are likely to be partly offset by higher expenses.
Why Should You Hold Assurant (AIZ) Stock in Your Portfolio?
by Zacks Equity Research
Higher trade-in volumes, international earnings, and income from fixed maturity securities, and a solid capital management policy continue to drive Assurant (AIZ).
Is a Beat in Store for Marsh & McLennan (MMC) in Q3 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) third-quarter results are likely to reflect revenue and earnings growth owing to solid performances by its Risk and Insurance Services, and Consulting segments.
What's in the Cards for Travelers (TRV) in Q3 Earnings?
by Zacks Equity Research
Travelers' (TRV) third-quarter results are likely to reflect new business premiums, strong retention rates, better pricing, partly offset by higher expenses.
Reasons Why EverQuote (EVER) Stock is an Attractive Pick
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from inorganic growth, solid performance of automotive insurance providers and financial flexibility.
Here's Why You Should Add Radian Group (RDN) to Your Portfolio
by Zacks Equity Research
Improving mortgage insurance portfolio, declining claims, the well-performing homegenius segment and solid capital position poise Radian Group (RDN) well for growth.
MetLife (MET) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 29.03% and 10.69%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
CNO Financial (CNO) Tops Q2 Earnings Estimates
by Zacks Equity Research
CNO (CNO) delivered earnings and revenue surprises of 80.85% and 4.94%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Lemonade (LMND) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Lemonade (LMND) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Horace Mann (HMN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Horace Mann (HMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for July 15th
by Zacks Equity Research
ACER, HMN, and STT have been added to the Zacks Rank #5 (Strong Sell) List on July 15, 2022.
Horace Mann (HMN) Estimates Q2 Cat Loss, Trims 2022 Guidance
by Zacks Equity Research
Horace Mann's (HMN) lowered guidance for 2022 reflects estimated cat loss and equity market declines.
Horace Mann (HMN) Okays Share Buyback Authorization of $50M
by Zacks Equity Research
Horace Mann (HMN) estimates generating about $50 million in excess capital annually in 2022 and beyond to support growth initiatives, buy back shares and hike dividends
Everest Re (RE) Rewards Shareholders With 6.4% Dividend Hike
by Zacks Equity Research
Everest Re's (RE) recent 6.4% hike in dividend reflects its intention to enhance shareholders' value, supported by its strong financial position.